Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference40 articles.
1. Revisions in the International system for staging lung cancer;Mountain;Chest,1997
2. Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non-small cell carcinoma. Results from a randomized phase II trial;Dautzenberg;Cancer,1990
3. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis;Pass;Ann Thorac Surg,1992
4. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial;Rosell;Lung Cancer,1999
5. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer;Roth;Lung Cancer,1998
Cited by 183 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future;Japanese Journal of Clinical Oncology;2024-08-20
2. Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Early-Stage Non-Small-Cell Lung Cancer;Current Oncology;2024-01-12
3. Evaluation of Clinical Guideline for the Diagnosis and Treatment of Non-Small Cell Lung Cancer (Nsclc) in Iran Using the Guideline Appraisal with Agree Ii;2024
4. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges;Frontiers in Oncology;2023-12-08
5. Evaluation of the clinical guidelines for the diagnosis and treatment of non-small cell lung cancer (NSCLC) in Iran via the guideline appraisal with AGREE II;2023-11-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3